See also this year's filing and all EDGAR filings for this company.
PDF Report 0001369786_2015_Sagent_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001369786, Sagent Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 198,518,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 93,730,000 |
| 2 | PropertyPlantAndEquipmentNet | 71,153,000 |
| 3 | remainder_Assets | 18,087,000 |
| 4 | LiabilitiesCurrent | 85,551,000 |
| 5 | LiabilitiesNoncurrent | 4,479,000 |
| 6 | remainder_Liabilities | 15,706,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 46,016,314 |
| 9 | ResearchAndDevelopmentExpense | 32,456,116 |
| 10 | remainder_Expenses | 179,705,494 |
| 11 | remainder_Revenues | 311,181,020 |
| 12 | remainder_NetIncome | 7,910,555 |
| 13 | remainder_ComprehensiveNetIncome | -8,523,971 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 381,488,000 |
| 1 | Liabilities | 105,736,000 |
| 2 | Expenses | 258,177,924 |
| 3 | Revenues | 311,181,020 |
| 4 | StockholdersEquity | 275,752,000 |
| 5 | NetIncome | 60,913,651 |
| 6 | ComprehensiveNetIncome | 56,651,666 |
| 7 | BaseVar | 536,508,735 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.70 |
| 9 | EconomicCapitalRatio | 3.49 |
Edgar->Model Mapping
Feature Distribution
Change over Time
